Inoviq Ltd (AU:IIQ) has released an update.
INOVIQ Ltd, a biotech firm specializing in cancer diagnostics and therapeutics, successfully held its Extraordinary General Meeting (EGM), where all resolutions were passed by a majority of votes. The resolutions included the approval of shares and options and ratifications related to the company’s share option plan (SPP) and placements. INOVIQ continues to make strides in commercializing its innovative EXO-NET technology and developing clinical-stage diagnostics for various cancers.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
